Healthcare provider profile · identity verified

Andrew J Hall, M.D.

Internal Medicine · CARLSBAD, CA · NPI 1154494565

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	477	144
Amlodipine Besylate	Amlodipine Besylate	324	99
Levothyroxine Sodium	Levothyroxine Sodium	222	64
Losartan Potassium	Losartan Potassium	170	52
Lisinopril	Lisinopril	165	53
Valsartan	Valsartan	149	47
Rosuvastatin Calcium	Rosuvastatin Calcium	148	50
Pantoprazole Sodium	Pantoprazole Sodium	140	48
Metoprolol Succinate	Metoprolol Succinate	126	40
Tamsulosin Hcl	Tamsulosin Hcl	108	38
Furosemide	Furosemide	105	34
Ozempic	Semaglutide	104	25
Alendronate Sodium	Alendronate Sodium	101	36
Gabapentin	Gabapentin	98	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	98	30
Zolpidem Tartrate	Zolpidem Tartrate	92	19
Metformin Hcl Er	Metformin Hcl	90	33
Tramadol Hcl	Tramadol Hcl	86	17
Simvastatin	Simvastatin	84	26
Trazodone Hcl	Trazodone Hcl	82	24
Metformin Hcl	Metformin Hcl	75	25
Duloxetine Hcl	Duloxetine Hcl	71	21
Eliquis	Apixaban	70	25
Carvedilol	Carvedilol	65	22
Omeprazole	Omeprazole	63	22
Allopurinol	Allopurinol	62	22
Sertraline Hcl	Sertraline Hcl	59	24
Mirtazapine	Mirtazapine	57	17
Atenolol	Atenolol	56	15
Fluoxetine Hcl	Fluoxetine Hcl	55	16
Shingrix	Varicella-Zoster Ge/As01b/Pf	55	40
Clopidogrel	Clopidogrel Bisulfate	54	17
Fluticasone Propionate	Fluticasone Propionate	51	suppressed
Spironolactone	Spironolactone	51	17
Finasteride	Finasteride	50	16
Alprazolam	Alprazolam	48	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	48	15
Synthroid	Levothyroxine Sodium	44	15
Bupropion Xl	Bupropion Hcl	41	16
Hydrochlorothiazide	Hydrochlorothiazide	41	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	13
Venlafaxine Hcl Er	Venlafaxine Hcl	38	11
Albuterol Sulfate Hfa	Albuterol Sulfate	36	16
Temazepam	Temazepam	35	suppressed
Donepezil Hcl	Donepezil Hcl	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	13
Triamcinolone Acetonide	Triamcinolone Acetonide	34	23
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Estradiol	Estradiol	32	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	31	suppressed
Meloxicam	Meloxicam	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Acyclovir	Acyclovir	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Famotidine	Famotidine	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Risperidone	Risperidone	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Lubiprostone	Lubiprostone	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	15
Verapamil Er	Verapamil Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Potassium Chloride	Potassium Chloride	19	suppressed
Fentanyl	Fentanyl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Estradiol (Once Weekly)	Estradiol	15	suppressed
Felodipine Er	Felodipine	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Movantik	Naloxegol Oxalate	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Indapamide	Indapamide	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error